Related Experiment Video
Updated: Sep 27, 2025
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Seizures and Epilepsy in Childhood
Insights
Pediatric epilepsy, the most common childhood neurologic disorder, requires accurate diagnosis and tailored treatments. Advances in genetic understanding and therapies like ketogenic diets and surgery offer improved outcomes and quality of life for affected children.
Area of Science:
- Pediatric Neurology
- Clinical Epilepsy Research
Background:
- Epilepsy is the most common neurologic disorder in childhood.
- Accurate diagnosis is crucial, distinguishing epileptic seizures from nonepileptic events in older children and recognizing subclinical seizures in neonates.
Purpose of the Study:
- To review basic concepts of seizures and epilepsy in pediatric patients.
- To outline fundamental treatment principles for childhood epilepsy.
Main Methods:
- Review of current literature on pediatric seizures and epilepsy.
- Synthesis of diagnostic and therapeutic approaches in pediatric epilepsy management.
Main Results:
- Antiseizure medications are first-line treatments; ketogenic diet and epilepsy surgery are effective alternatives.
- Genetic factors account for ~30% of cases, with a shift towards understanding genetic spectrums.
- Precision medicine shows promise but requires further clinical integration.
Conclusions:
- Optimal treatment and early access to specialist care positively impact prognosis and neurodevelopment.
- Improving quality of life for children with epilepsy and their families is the primary goal.
Purpose Of Review:
This article highlights basic concepts of seizures and epilepsy in pediatric patients, as well as basic treatment principles for this age group.
Recent Findings:
Epilepsy is the most common neurologic disorder in childhood. Accurate diagnosis is key; in older children, epileptic seizures need to be differentiated from various paroxysmal nonepileptic events, whereas in neonates, the majority of seizures are subclinical (electroencephalographic). Antiseizure medications remain the first-line treatment, but ketogenic diet and epilepsy surgery have also shown positive outcomes and can decrease drug burden. Genetic causes account for approximately 30% of cases, and the recognition of electroclinical syndromes is being replaced by the concept of genetic spectrums. Precision medicine therapies are promising, but wide application in daily practice still has a long way to go. Early access to specialist centers and optimal treatments positively affects prognosis and future neurodevelopment.
Summary:
Although novel findings from all fields of research are being incorporated into everyday clinical practice, a better quality of life for children with seizures and epilepsy and their families is the ultimate priority.
Related Concept Videos
01:13Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists